Skip to main content
Signal8

Lonza Group AG (LZAGY)

Sector: Biotechnology

Industry: Biotechnology

Lonza Group AG logo

Lonza Group AG

OTC:LZAGYHealthcare
-0.03%$79.23
CLOSED
Mkt Cap$56.37B
EV-
Float69.81M
O/S711.53M
VOL27K sh
$ Vol$2.17M
RVOL0.66×
Inst Own-
SI0.1%
Net Cash/Sh-
EarningsJan 27 · in 2mo
Div Yield0.72%
Dilution
Lonza Group AG logoOTC:LZAGYClosed$79.23-0.03%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 202680.2580.2679.2379.2327,182
Nov 13, 202679.4779.5179.1779.2526,807
Nov 12, 202679.5979.8479.1979.3034,196
Nov 11, 202679.3680.0479.3279.7534,049
Nov 10, 202679.9880.4779.6880.4126,595
Nov 9, 202680.7881.3380.0781.0642,098
Nov 6, 202680.1081.2680.1080.7537,234
Nov 5, 202682.1682.6381.6481.90126,681
Nov 4, 202681.4981.5080.6581.4430,634
Nov 3, 202679.0979.7779.0579.2129,254
Nov 2, 202679.1379.4878.8279.3142,938
Oct 30, 202678.5078.7877.6777.8425,023
Oct 29, 202677.1477.5976.8477.5728,741
Oct 28, 202675.1076.3075.0875.9244,972
Oct 27, 202675.9576.9075.7176.8949,185
Oct 26, 202676.7276.7476.3376.5622,036
Oct 23, 202676.7677.0476.2876.5432,439
Oct 22, 202676.5076.8576.2076.69128,719
Oct 21, 202675.0675.5875.0175.3122,272
Oct 20, 202675.6576.1775.4075.9420,323
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
0
SELL
0
TOTAL1
About

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products.

It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment design, development, and manufacturing, with the ability to offer integrated drug substances to drug product solutions, including particle engineering and drug product packaging. The Cell and Gene segment develops, de-risk, commercializes, and scales their emerging therapies through its three business areas Cell and Gene Technologies, Bioscience, and Personalized Medicine. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions.

The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.

Key Metrics
Market Cap$56.37B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 711.53M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryCHCH
IPO Date-
Shares Outstanding711.53M
Authorized Shares
Float69.81M
52-Week Range
$58.53$82.63
$79.23(86th percentile)
Volume
Average Daily Volume41.20K
27.18K today vs 41.20K avg(-34%)

30d Avg

41.20K

60d Avg

46.20K

90d Avg

45.53K

Earnings
Dividend History
TTM Yield
0.72%
Paid annually
Annual (LTM)
$0.57
Latest
$0.5707
May 13, 26
5Y Growth
+12.91%
per year

Lonza Group AG (OTC: LZAGY) traded at $79.23 on Nov 16, 2026, down 0.03% from the previous close of $79.25. 52-week range: $58.53 to $82.63. The company is in the Healthcare sector (Biotechnology).